Equine CYP2B6: genomic annotation, heterologous expression and its role in the metabolism of ketamine

被引：0

作者：

Schmitz, A. ^{[1
]}

Peters, L. ^{[2
]}

Demmel, S. ^{[2
]}

Haase, B. ^{[3
]}

Buters, J. ^{[4
]}

Thormann, W. ^{[5
]}

Leeb, T. ^{[3
]}

Mevissen, M. ^{[2
]}

机构：

[1] Univ Bern, Bern, Switzerland

[2] Uni Bern, Vetsuisse Fac, Div Vet Pharmacol & Toxicol, Bern, Switzerland

[3] Uni Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland

[4] Tech Univ Munich, Helmholtz Zentrum Munchen, ZAUM Ctr Allergy & Environm, Munich, Germany

[5] Uni Bern, Inst Infect Dis, Clin Pharmacol Lab, Bern, Switzerland

来源：

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 2012年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：10 / 10

页数：1

共 50 条

[31] CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people [J].

Binnington, Matthew J. ;

Zhu, Andy Z. X. ;

Renner, Caroline C. ;

Lanier, Anne P. ;

Hatsukami, Dorothy K. ;

Benowitz, Neal L. ;

Tyndale, Rachel F. .

PHARMACOGENETICS AND GENOMICS, 2012, 22 (06) :429-440

[32] Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism [J].

Ring, Huijun Z. ;

Valdes, Ana M. ;

Nishita, Denise M. ;

Prasad, Suman ;

Jacob, Peyton, III ;

Tyndale, Rachel F. ;

Swan, Gary E. ;

Benowitz, Neal L. .

PHARMACOGENETICS AND GENOMICS, 2007, 17 (12) :1007-1015

[33] Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes [J].

Yanagihara, Y ;

Kariya, S ;

Ohtani, M ;

Uchino, K ;

Aoyama, T ;

Yamamura, Y ;

Iga, T .

DRUG METABOLISM AND DISPOSITION, 2001, 29 (06) :887-890

[34] Characterization of CYP2B6 in a CYP2B6-Humanized Mouse Model: Inducibility in the Liver by Phenobarbital and Dexamethasone and Role in Nicotine Metabolism In Vivo [J].

Liu, Zhihua ;

Li, Lei ;

Wu, Hong ;

Hu, Jing ;

Ma, Jun ;

Zhang, Qing-Yu ;

Ding, Xinxin .

DRUG METABOLISM AND DISPOSITION, 2015, 43 (02) :208-216

[35] PharmVar GeneFocus: CYP2B6 [J].

Desta, Zeruesenay ;

El-Boraie, Ahmed ;

Gong, Li ;

Somogyi, Andrew A. ;

Lauschke, Volker M. ;

Dandara, Collet ;

Klein, Kathrin ;

Miller, Neil A. ;

Klein, Teri E. ;

Tyndale, Rachel F. ;

Whirl-Carrillo, Michelle ;

Gaedigk, Andrea .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) :82-97

[36] Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: A crucial role for the CYP2B6*6 allele [J].

Hwang, In Cheol ;

Park, Ji Young ;

Ahn, Hong Yup ;

Kim, Kyoung Kon ;

Suh, Heuy Sun ;

Ko, Ki Dong ;

Kim, Kyoung-Ah .

CLINICA CHIMICA ACTA, 2014, 428 :77-81

[37] METHADONE ENANTIOMERS METABOLISM AND CLEARANCE ARE IMPAIRED IN INDIVIDUALS WITH CYP2B6*6 GENOTYPE [J].

Kharasch, E. D. ;

Parchomski, J. ;

Regina, K. ;

Blood, J. ;

Yang, Y. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 :S53-S54

[38] The functional role of CYP2B6 in human drug metabolism:: Substrates and inhibitors in vitro, in vivo and in silico [J].

Turpeinen, Miia ;

Raunio, Hannu ;

Pelkonen, Olavi .

CURRENT DRUG METABOLISM, 2006, 7 (07) :705-714

[39] The CYP2B6*6 Allele Significantly Alters the N-Demethylation of Ketamine Enantiomers In Vitro [J].

Li, Yibai ;

Coller, Janet K. ;

Hutchinson, Mark R. ;

Klein, Kathrin ;

Zanger, Ulrich M. ;

Stanley, Nathan J. ;

Abell, Andrew D. ;

Somogyi, Andrew A. .

DRUG METABOLISM AND DISPOSITION, 2013, 41 (06) :1264-1272

[40] Oxidative Metabolism of BDE-99 by Human Liver Microsomes: Predominant Role of CYP2B6 [J].

Erratico, Claudio A. ;

Szeitz, Andras ;

Bandiera, Stelvio M. .

TOXICOLOGICAL SCIENCES, 2012, 129 (02) :280-292

← 1 2 3 4 5 →